Search

everythinglearnresearchcommunity

for

Search:↓

The Endocrine Society advised against routine testosterone therapy for women, citing a need for more research on long-term safety and a clear definition of androgen deficiency.

The NAMS 2014 recommendations guide healthcare providers on treating health issues in midlife women, emphasizing individualized care and informed decision-making.

Multimedia education greatly improves women's knowledge and management of PCOS.

Obese women with PCOS are more likely to have fatty liver disease.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

South Asian women with PCOS are more likely to have metabolic issues and central obesity, and simple measures like waist size and blood pressure can help identify these risks early.

PCOS and lifestyle choices like diet and hair removal methods play a key role in moderate hirsutism.

Patients with chronic graft-versus-host disease often have skin problems like vitiligo and alopecia areata.

Consider benefits and risks of new alopecia treatments for safety.

Scalp cooling significantly reduces hair loss in chemotherapy patients.

New treatment reduces hair shedding and increases hair density in women with early hair loss.

Low-dose flutamide improved hirsutism and satisfaction in women but had common side effects, causing some to stop treatment.

A standard protocol for alopecia areata clinical trials was created to improve consistency and encourage more research.

Hormonal changes and psychological issues can cause sexual dysfunction in postmenopausal women. Behavioral therapy is recommended first, with hormone replacement helping some symptoms but not libido. Testosterone can improve libido, but its effects on overall sexual function are unclear. Emotional and relationship issues should be addressed before using medication, and the benefits and risks of testosterone supplementation should be considered.

PCOS is common among Chinese women of reproductive age and linked to serious metabolic and reproductive issues, especially in obese women.

Testosterone may help increase sexual events for women with low libido due to antidepressants.

Low prolactin in young women may increase heart and metabolism risks.

Androgen therapy might help some women with low libido, but it has risks and should be used carefully.

Individualized treatment and support can help most couples with recurrent implantation failure achieve pregnancy.

Machine learning can accurately predict Polycystic Ovary Syndrome in women using clinical features.

Metformin reduces high male hormone levels in women with PCOS.

Autologous platelet concentrates show promise in esthetic treatments but need more standardized research.

Endometriosis causes abdominal-pelvic pain, and while surgery and treatments help, pain often persists.

The report recommends personalized treatment for women's sexual dysfunctions and more research on effective therapies.

Testosterone therapy may slightly improve sexual function in postmenopausal women, but its long-term safety is unknown.

Depression is more common in infertile women with PCOS than those without.

High-dose radioactive iodine therapy does not harm fertility in thyroidectomy patients.

SLFC can improve scalp health and reduce sensitive scalp symptoms.

Certain gene variations in AKT2 are more common in women with PCOS and are linked to higher levels of specific hormones and symptoms.

Understanding hair health and disorders is important for effective treatment.